Depression
Conference Coverage
National poll shows ‘concerning’ impact of COVID on Americans’ mental health
In the new poll, about 4 in 10 Americans (41%) report they are more anxious than last year, down from just over 60%.
Feature
The cloudy role of cannabis as a neuropsychiatric treatment
Medical cannabis has been made widely available to patients and has largely outpaced the clinical evidence.
From the Journals
Nurses or physicians: Who are at highest suicide risk?
“The main takeaway is that the risk of suicide among nurses is twice that of the general population and even higher than that among physicians,”...
From the Journals
Psilocybin matches SSRI for moderate to severe depression in phase 2 study
“It’s very clear that psilocybin therapy has a faster antidepressant onset than escitalopram,” said lead author Robin Carhart-Harris, PhD.
Opinion
Shedding the super doctor myth
“How do we see beyond the illusion of invulnerability and accept that vulnerability is not a sign of weakness but a hallmark of strength and...
From the Journals
Adult separation anxiety raises suicidality risk
The DSM-5 expanded the diagnosis to include adults over 18 years of age because research had “found a later onset to be common.”
Commentary
How physicians can provide better care to transgender patients
Those transgender patients who seek care often have unpleasant experiences.
Feature
An international trip: Global experts weigh in on psychedelics
In most, if not all, countries, it is still illegal to prescribe psychedelics in other than a research setting.
Feature
Rhythm and blues: Using heart rate to diagnose depression
“What we’re trying to do is develop interventions not only for depression but also for the associated physical health problems ... said Dr. Amit...
From the Journals
Child abuse tied to persistent inflammation in later life
Participants who had reported childhood abuse also demonstrated significantly higher rates of loneliness and depression.
From the Journals
New expert guidance on ketamine for resistant depression
The group advises that esketamine and ketamine be administered only in settings with multidisciplinary personnel.